[Adverse effects of intravenous human polyvalent immunoglobulins].
Chapuis
C
C
Pharmacie centrale, Centre Hospitalier Universitaire, Grenoble, France. CChapuis1@chu-grenoble.fr
Guy
N
N
Besson
G
G
D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D020275:Guillain-Barre Syndrome / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D008297:Male; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000453:epidemiology; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
D016756:Immunoglobulins, Intravenous